Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

Randomized, allopurinol-controlled trial of the effects of dietary nucleotides and active hexose correlated compound in the treatment of canine leishmaniosis.

Segarra S, Miró G, Montoya A, Pardo-Marín L, Boqué N, Ferrer L, Cerón J.

Vet Parasitol. 2017 May 30;239:50-56. doi: 10.1016/j.vetpar.2017.04.014. Epub 2017 Apr 23.

2.

Prevention of disease progression in Leishmania infantum-infected dogs with dietary nucleotides and active hexose correlated compound.

Segarra S, Miró G, Montoya A, Pardo-Marín L, Teichenné J, Ferrer L, Cerón JJ.

Parasit Vectors. 2018 Feb 21;11(1):103. doi: 10.1186/s13071-018-2705-z.

3.

Long-term follow-up of dogs with leishmaniosis treated with meglumine antimoniate plus allopurinol versus miltefosine plus allopurinol.

Manna L, Corso R, Galiero G, Cerrone A, Muzj P, Gravino AE.

Parasit Vectors. 2015 May 28;8:289. doi: 10.1186/s13071-015-0896-0.

4.

Clinical and serological follow-up in dogs with visceral leishmaniosis treated with allopurinol and sodium stibogluconate.

Pasa S, Toz SO, Voyvoda H, Ozbel Y.

Vet Parasitol. 2005 Mar 31;128(3-4):243-9.

PMID:
15740861
5.

Effectiveness of the sesquiterpene (-)-α-bisabolol in dogs with naturally acquired canine leishmaniosis: an exploratory clinical trial.

Corpas-López V, Merino-Espinosa G, Acedo-Sánchez C, Díaz-Sáez V, Navarro-Moll MC, Morillas-Márquez F, Martín-Sánchez J.

Vet Res Commun. 2018 Jun;42(2):121-130. doi: 10.1007/s11259-018-9714-4. Epub 2018 Feb 16.

PMID:
29453596
6.

Leishmania infantum-specific IFN-γ production in stimulated blood from dogs with clinical leishmaniosis at diagnosis and during treatment.

Martínez-Orellana P, Marí-Martorell D, Montserrat-Sangrà S, Ordeix L, Baneth G, Solano-Gallego L.

Vet Parasitol. 2017 Dec 15;248:39-47. doi: 10.1016/j.vetpar.2017.10.018. Epub 2017 Oct 29.

PMID:
29173539
7.

Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis.

Miró G, Oliva G, Cruz I, Cañavate C, Mortarino M, Vischer C, Bianciardi P.

Vet Dermatol. 2009 Oct;20(5-6):397-404. doi: 10.1111/j.1365-3164.2009.00824.x.

PMID:
20178476
8.

Prospective evaluation of serum pancreatic lipase immunoreactivity and troponin I concentrations in Leishmania infantum-infected dogs treated with meglumine antimonate.

Xenoulis PG, Saridomichelakis MN, Chatzis MK, Kasabalis D, Petanides T, Suchodolski JS, Steiner JM.

Vet Parasitol. 2014 Jul 14;203(3-4):326-30. doi: 10.1016/j.vetpar.2014.03.033. Epub 2014 Apr 12.

PMID:
24813787
9.

Study of efficacy of miltefosine and allopurinol in dogs with leishmaniosis.

Manna L, Vitale F, Reale S, Picillo E, Neglia G, Vescio F, Gravino AE.

Vet J. 2009 Dec;182(3):441-5. doi: 10.1016/j.tvjl.2008.08.009. Epub 2008 Sep 24.

PMID:
18818112
10.

TLR-2 and TLR-4 transcriptions in unstimulated blood from dogs with leishmaniosis due to Leishmania infantum at the time of diagnosis and during follow-up treatment.

Montserrat-Sangrà S, Alborch L, Ordeix L, Solano-Gallego L.

Vet Parasitol. 2016 Sep 15;228:172-179. doi: 10.1016/j.vetpar.2016.09.005. Epub 2016 Sep 9.

PMID:
27692322
11.

Effect of two treatments on changes in serum acute phase protein concentrations in dogs with clinical leishmaniosis.

Daza González MA, Fragío Arnold C, Fermín Rodríguez M, Checa R, Montoya A, Portero Fuentes M, Rupérez Noguer C, Martínez Subiela S, Cerón JJ, Miró G.

Vet J. 2019 Mar;245:22-28. doi: 10.1016/j.tvjl.2018.12.020. Epub 2018 Dec 19.

PMID:
30819422
12.

Changes in the concentration of anti-Leishmania antibodies in saliva of dogs with clinical leishmaniosis after short-term treatment.

Cantos-Barreda A, Escribano D, Cerón JJ, Tecles F, Bernal LJ, Martínez-Subiela S.

Vet Parasitol. 2018 Apr 30;254:135-141. doi: 10.1016/j.vetpar.2018.03.014. Epub 2018 Mar 13.

PMID:
29656998
13.

Cutaneous immune mechanisms in canine leishmaniosis due to Leishmania infantum.

Papadogiannakis EI, Koutinas AF.

Vet Immunol Immunopathol. 2015 Feb 15;163(3-4):94-102. doi: 10.1016/j.vetimm.2014.11.011. Epub 2014 Nov 20. Review.

PMID:
25555497
14.

Serum concentrations of acute-phase proteins in dogs with leishmaniosis during short-term treatment.

Martínez-Subiela S, Bernal LJ, Cerón JJ.

Am J Vet Res. 2003 Aug;64(8):1021-6.

PMID:
12926596
15.

Chemotherapy of canine leishmaniosis.

Baneth G, Shaw SE.

Vet Parasitol. 2002 Jul 2;106(4):315-24. Review.

PMID:
12079737
16.

Comparison of different tissue sampling for PCR-based diagnosis and follow-up of canine visceral leishmaniosis.

Manna L, Vitale F, Reale S, Caracappa S, Pavone LM, Morte RD, Cringoli G, Staiano N, Gravino AE.

Vet Parasitol. 2004 Nov 10;125(3-4):251-62.

PMID:
15482882
17.

PCR follow-up examination after treatment of canine leishmaniosis (CaL).

Steuber S, Moritz A, Schirrmann I, Greiner M.

Tokai J Exp Clin Med. 1998 Dec;23(6):285-92.

PMID:
10622624
18.

[Canine leishmaniasis: evolution of the chemotherapeutic protocols].

Oliva G, Foglia Manzillo V, Pagano A.

Parassitologia. 2004 Jun;46(1-2):231-4. Review. Italian.

PMID:
15305724
19.

Thyroid function in 36 dogs with leishmaniosis due to Leishmania infantum before and during treatment with allopurinol with or without meglumine antimonate.

Saridomichelakis MN, Xenoulis PG, Chatzis MK, Kasabalis D, Steiner JM, Suchodolski JS, Petanides T.

Vet Parasitol. 2013 Oct 18;197(1-2):22-8. doi: 10.1016/j.vetpar.2013.04.038. Epub 2013 Apr 26.

PMID:
23685064
20.

The effects of prednisone on haemostasis in leishmaniotic dogs treated with meglumine antimoniate and allopurinol.

Cortese L, Pelagalli A, Piantedosi D, Mastellone V, Di Loria A, Lombardi P, Ciaramella P, Avallone L.

Vet J. 2008 Sep;177(3):405-10. Epub 2007 Jul 12.

PMID:
17629526

Supplemental Content

Support Center